Systems Biology Opens the Blackest Boxes
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Bringing Pharmacogenomics into the Clinic
Companies Can't Afford Not to Use Genomic Tools in their Clinical Studies
- Biomarkers are capable of bridging the distance between basic research and late-stage clinical trials and can even shorten it. Many pharmaceutical and biotech companies are investing additional resources to bring biomarkers into the clinic. They hope that these efforts to practice pharmacogenomic research both in the preclinical and clinical ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.